Discovery of New Plasma Protein Biomarkers Linked to Knee Osteoarthritis Through Human Proteome Integration: Insights from Mendelian Randomization and Initial In Vitro Studies - Top-Institutions - MDSpire

Discovery of New Plasma Protein Biomarkers Linked to Knee Osteoarthritis Through Human Proteome Integration: Insights from Mendelian Randomization and Initial In Vitro Studies

  • By

  • Wang Huang

  • WeiWei Hu

  • JiaYu Chen

  • Dan Yuan

  • April 22, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Broad Institute of MIT and Harvard
    Broad Institute of MIT and Harvard

    Cambridge, MA

    Key Differentiators

    • Genomic Medicine
    • Proteomics
    • Rheumatology Research

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Rheumatology
    • Inflammation Biology
    • Proteomics

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Rheumatology
    • Genetic Epidemiology
    • Proteomics

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Orthopedics
    • Rheumatology
    • Biomarker Discovery

  • #5

    University of Oxford
    University of Oxford

    Oxford, UK

    Key Differentiators

    • Musculoskeletal Epidemiology
    • Genetics
    • Inflammation Research

Original Source(s)

Discovery of New Plasma Protein Biomarkers Linked to Knee Osteoarthritis Through Human Proteome Integration: Insights from Mendelian Randomization and Initial In Vitro Studies

  • by Wang Huang, WeiWei Hu, JiaYu Chen, Dan Yuan

  • April 22, 2026

Related Content

Impact of Sulfate-Arsenical-Ferruginous Water on Apoptosis, Oxidative Stress, and Gene Expression of Inflammatory Mediators and MicroRNA in Human Osteoarthritic Chondrocytes Stimulated by IL-1β

PT vs CBT for Chronic Low Back Pain

Sequential, multiple-assignment randomized trial compares stage I and stage II nonpharmacologic treatments over 52 weeks.

Kinesio Taping Shows Limited, Uncertain Benefits

Researchers find effects vary by timing, comparator, and outcome across musculoskeletal disorders